The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
Official Title: PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER EFFICACY AND SAFETY STUDY OF TANEZUMAB AS ADD-ON THERAPY TO OPIOID MEDICATION IN PATIENTS WITH PAIN DUE TO BONE METASTASES
Study ID: NCT00545129
Brief Summary: The purpose of this study is to investigate the safety and efficacy of tanezumab in combination with opioids in treating pain due to cancer that has spread to bone.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
UCSD Center for Pain Medicine, La Jolla, California, United States
UCSD Medical Center - Thornton Hospital, La Jolla, California, United States
UCSD Moores Cancer Center, La Jolla, California, United States
Indiana Pain and Spine Clinic, South Bend, Indiana, United States
WK River Cities Clinical Research Center, Shreveport, Louisiana, United States
Willis Knighton Pierremont Health Center, Shreveport, Louisiana, United States
Hollings Cancer Center, Charleston, South Carolina, United States
Medical University of South Carolina, Department of Urology, Charleston, South Carolina, United States
MUSC Department of Radiology, Charleston, South Carolina, United States
MUSC Investigational Pharmacy, Charleston, South Carolina, United States
MUSC Urology Ambulatory Care, Charleston, South Carolina, United States
Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, United States
Landeskrankenhaus Graz - Universitaetsklinik fuer Orthopaedie und Orthopaedische Chirurgie, Graz, , Austria
Krankenhaus der Elisabethinen Linz, Institut fuer Anaesthesiologie und Intensivmedizin, Linz, , Austria
Nuhr Zentrum, Senftenberg, , Austria
Clinic of Oncology, Banja Luka, , Bosnia and Herzegovina
Institute of Oncology, University Clinical Center Sarajevo, Sarajevo, , Bosnia and Herzegovina
General Hospital Varazdin, Varazdin, , Croatia
Institut Gustave Roussy, Villejuif, , France
Fovarosi Onkormanyzat Peterfy Sandor Utcai Korhaz - Fajdalom Ambulancia, Budapest, , Hungary
Fovarosi Onkormanyzat Jahn Ferenc Del-pesti Korhaz - Fajdalom Ambulancia, Budapest, , Hungary
Fejer Megyei Szt. Gyorgy Korhaz - Rendelointezet/Aneszteziologiai es Intenziv Betegellato Osztaly, Szekesfehervar, , Hungary
Shri Siddhivinayak Ganpati Cancer Hospital, Miraj, Maharashtra, India
Central India Cancer Research Institute, Nagpur, Maharashtra, India
Shatabdi Superspeciality Hospital, Nashik, Maharashtra, India
Chhatrapati Shahuji Maharaj Medical University, Lucknow, Uttar Pradesh, India
Rajiv Gandhi Cancer Institute and Research Centre,, New Delhi, , India
Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center, Seoul, , Korea, Republic of
Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Seoul, , Korea, Republic of
10th Department, Latvian Oncological Centre / Riga Eastern Clinical University Hospital, Riga, , Latvia
Centro de Cancer del Centro Medico ABC, Mexico, Distrito Federal, Mexico
Hospital Nacional Guillermo Almenara Irigoyen, Lima, Lima L13, Peru
Oncocare, Lima, , Peru
Niepubliczny Zaklad Opieki Zdrowotnej, Bydgoszcz, , Poland
Hospicjum im. Ks. Eugeniusza Dutkiewicza SAC w Gdansku, Gdansk, , Poland
Poradnia Medycyny Paliatywnej, Hospicjum Palium, Poznan, , Poland
NZOZ Zespol Opieki Domowej, Wloclawek, , Poland
Fakultna Nemocnica s Poliklinikou F.D.Roosevelta, Banska Bystrica, , Slovakia
Narodny onkologicky ustav, Bratislava, , Slovakia
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR